U.S., Feb. 22 -- ClinicalTrials.gov registry received information related to the study (NCT06839443) titled 'Deep Learning in the Detection and Prediction of Hydroxychloroquine Maculopathy' on Feb. 17.
Brief Summary: Hydroxychloroquine retinal toxicity affects a significant number of patients using this medication. Detection of toxicity is difficult in the early stages of the disease and depends on the subjectivity of the clinician who reads the tests (optical coherence tomography, autofluorescence and visual fields). Automating the reading of these diagnostic exams could lead to earlier detection of this pathology and reduce the burden associated with interpreting these exams in the ophthalmology service. The images that are usually taken...